Teva stock jumps after company reaches tentative $4.25B opioid litigation settlement deal
July 27, 2022 at 10:21 AM EDT
Teva acquired two branded opioid products when it bought Chester County-based Cephalon in 2011.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|